Rosiglitazone Does Not Improve Cognition or Global Function when Used as Adjunctive Therapy to AChE Inhibitors in Mild-to-Moderate Alzheimer's Disease: Two Phase 3 Studies

Publisher: Bentham Science Publishers

E-ISSN: 1875-5828|8|5|592-606

ISSN: 1567-2050

Source: Current Alzheimer Research, Vol.8, Iss.5, 2011-08, pp. : 592-606

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content